The level of IL-6 was significantly elevated in AML patients compared to controls (Supplementary Fig. 3A, P < 0.0001) with similar expression in males and females (Supplementary Fig. 3B) and between molecular subgroups (Supplementary Fig. 3C–E). Here, IL6 is linked to acute myeloid leukemia.